🇺🇸 FDA
Patent

US 9943565

Methods and compositions for treating trinucleotide repeat disorders

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 9943565 (Methods and compositions for treating trinucleotide repeat disorders) held by Sangamo Therapeutics, Inc. expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P